FAM177A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.058220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.874200E-01
Normal-vs-Stage2
9.844200E-02
Normal-vs-Stage3
5.627000E-01
Normal-vs-Stage4
7.509600E-02
Stage1-vs-Stage2
2.564200E-01
Stage1-vs-Stage3
9.500000E-01
Stage1-vs-Stage4
3.326200E-02
Stage2-vs-Stage3
3.257000E-01
Stage2-vs-Stage4
3.756300E-02
Stage3-vs-Stage4
1.218960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.514500E-02
Normal-vs-AfricanAmerican
2.929000E-01
Normal-vs-Asian
3.936400E-01
Caucasian-vs-AfricanAmerican
6.434600E-01
Caucasian-vs-Asian
5.208800E-01
AfricanAmerican-vs-Asian
9.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.122570E-01
Normal-vs-Female
1.129840E-01
Male-vs-Female
7.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.444800E-01
Normal-vs-Age(41-60Yrs)
5.452200E-02
Normal-vs-Age(61-80Yrs)
1.494560E-01
Normal-vs-Age(81-100Yrs)
8.846500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.373000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.351600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.979000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.122200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.023200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.114400E-01
Normal-vs-Daily Drinker
2.171800E-01
Normal-vs-Weekly Drinker
3.160400E-01
Normal-vs-Occasional Drinker
5.353700E-02
Normal-vs-Social Drinker
1.438220E-01
Non Drinker-vs-Daily Drinker
9.513800E-01
Non Drinker-vs-Weekly Drinker
9.662600E-01
Non Drinker-vs-Occasional Drinker
5.115800E-02
Non Drinker-vs-Social Drinker
5.588800E-01
Daily Drinker-vs-Weekly Drinker
9.946800E-01
Daily Drinker-vs-Occasional Drinker
7.850100E-02
Daily Drinker-vs-Social Drinker
6.189800E-01
Weekly Drinker-vs-Occasional Drinker
1.502850E-01
Weekly Drinker-vs-Social Drinker
6.809400E-01
Occasional Drinker-vs-Social Drinker
2.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.651800E-02
Normal-vs-Grade 2
1.031750E-02
Normal-vs-Grade 3
1.922480E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.630450E-01
Grade 1-vs-Grade 3
1.838410E-01
Grade 1-vs-Grade 4
4.651800E-02
Grade 2-vs-Grade 3
8.313800E-01
Grade 2-vs-Grade 4
1.031750E-02
Grade 3-vs-Grade 4
1.922480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.025200E-01
Normal-vs-NonDiabetic
9.962300E-02
Diabetic-vs-NonDiabetic
2.043800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.144200E-01
Normal-vs-NoPancreatitis
1.149360E-01
Pancreatitis-vs-NoPancreatitis
1.807160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.490790E-01
Normal-vs-N1
9.623800E-02
N0-vs-N1
8.240600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.644200E-02
Normal-vs-TP53-NonMutant
3.179000E-01
TP53-Mutant-vs-TP53-NonMutant
1.185080E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
